SPY384.24+0.35 0.09%
DIA311.87+0.10 0.03%
IXIC13,530.92+73.67 0.55%

EyePoint Pharmaceuticals shares are trading higher. Not seeing any company-specific news to justify the price action. NOTE: Yesterday the company announced it received $9.5 million upfront payment after expanding an exclusive license agreement.

Benzinga · 08/21/2020 18:48